Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04528173 · ClinicalTrials.gov registry record · Phase 4
Opioid-Free Anesthetic for Tonsillectomy
A Phase 4 study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT04528173 is a Phase 4 study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 35 participants.
The verdict
NCT04528173, a Phase 4 study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
Prospective randomized controlled trial to determine if opioid-free anesthetic for tonsillectomy is non-inferior to standard opioid-containing anesthetic
Interventions
- DRUG Ketorolac
- DRUG Dexmedetomidine
- DRUG Morphine
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-07-22 |
| Est. Completion | 2023-08-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04528173
The ClinicalTrials.gov registry entry for NCT04528173 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ketorolac is the first listed.
NCT04528173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04528173 about?
NCT04528173 is a clinical study titled "Opioid-Free Anesthetic for Tonsillectomy". Prospective randomized controlled trial to determine if opioid-free anesthetic for tonsillectomy is non-inferior to standard opioid-containing anesthetic
What is the current status of trial NCT04528173?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2020-07-22. Estimated completion is 2023-08-22.
What interventions are being tested in trial NCT04528173?
The interventions under investigation include: Ketorolac (DRUG), Dexmedetomidine (DRUG), Morphine (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT04528173?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.